法规层面:
药品
支持补充210,211
212、 CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
215、CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
216、CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
606、 CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
独立于210、211
212、CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
食品:
110、CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKING, OR HOLDING HUMAN FOOD(人)
117、CURRENT GOOD MANUFACTURING PRACTICE, HAZARD ANALYSIS, AND RISK-BASED PREVENTIVE CONTROLS FOR HUMAN FOOD(人)
507、CURRENT GOOD MANUFACTURING PRACTICE, HAZARD ANALYSIS, AND RISK-BASED PREVENTIVE CONTROLS FOR FOOD FOR ANIMALS(动物)
part110和part117有什么区别???
膳食剂
111、CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
医疗器械:
820、QUALITY SYSTEM REGULATION
——————————————————————————————————————————————————————
指南层面:
药品:
支持210,211
Guidance for Industry Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice
独立于210、211
食品
????
膳食剂
????
医疗器械
????
化妆品:
????
稍整理了一下,还真不好理解美国的GMP,求指导!@一沙一叶 @julia朱玉娇 美国FDA的GMP结构是怎么样的呢??
|